MCL1 and colorectal carcinoma: Compared to FBW7-WT cells, FBW7-mutant CRC cells were much more refractory to regorafenib (Figure 2A and Figure S3A), and deficient in regorafenib-induced Mcl-1 degradation and apoptosis (Figure 2B and Figure S3B) 6.